Microtube Device for Selectin-Mediated Capture of Viable Circulating Tumor Cells from Blood

Abstract

The device successfully isolates viable CTCs from both blood and buffy coat samples. The approximately 50% capture rate with purities >50% with the nanotube coating demonstrates the functionality of this device in a clinical setting and opens the door for personalized cancer therapies.